and/or the use of either quinidine or procainamide in an attempt to convert the rhythm to sinus rhythm or to prevent recurrence of atrial flutter once sinus rhythm was established. The past 25 years ...

Amiodarone was started and sinus rhythm was achieved, but recurrences of AF and type I atrial flutter required further DC cardioversion. The patient was referred to a cardiac electro-physiologist ...

AF-CHF = Atrial Fibrillation and Congestive Heart ... from any cause in patiENts with Atrial fibrillation/atrial flutter; J-Rhythm = Japanese Rhythm Management Trial for Atrial Fibrillation ...

The atrial flutter market is growing as cardiovascular diseases become more common, and the aging population, which is more vulnerable to heart rhythm issues, continues to rise. Advancements in ...

HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

A 2024 study followed the outcomes of 260,492 adults hospitalized for AFib or atrial flutter, a closely related cardiac rhythm change. The authors reported 45% of the people had died within 10 years, ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

In patients admitted to a coronary care unit, atrial fibrillation or flutter with tachycardia is a major cause of haemodynamic instability. Amiodarone has been established to have a rapid frequency ...

A 2024 study followed the outcomes of 260,492 adults hospitalized for AFib or atrial flutter, a closely related cardiac rhythm change. The authors reported 45% of the people had died within 10 ...